Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05128227 · ClinicalTrials.gov registry record · NA
PHARM-S.A.V.E.S: Suicide Prevention Training
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 119
- Enrollment target
NCT05128227 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 119 participants.
The verdict
NCT05128227, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
Study Summary
This is a pilot Randomized Controlled Trial (RCT) in which 150 pharmacy staff members will be randomized to an experimental or control group and data on suicide prevention communication and secondary outcomes will be collected over the course of the RCT.
Interventions
- BEHAVIORAL Pharm-SAVES
- BEHAVIORAL Interactive video cases
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2022-04-15 |
| Est. Completion | 2023-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05128227
The ClinicalTrials.gov registry entry for NCT05128227 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pharm-SAVES is the first listed.
NCT05128227 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05128227 about?
NCT05128227 is a clinical study titled "PHARM-S.A.V.E.S: Suicide Prevention Training". This is a pilot Randomized Controlled Trial (RCT) in which 150 pharmacy staff members will be randomized to an experimental or control group and data on suicide prevention communication and secondary outcomes will be collected over the course of the RCT.
What is the current status of trial NCT05128227?
This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2022-04-15. Estimated completion is 2023-06-01.
What interventions are being tested in trial NCT05128227?
The interventions under investigation include: Pharm-SAVES (BEHAVIORAL), Interactive video cases (BEHAVIORAL).
Who is sponsoring clinical trial NCT05128227?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.